Publications Database

Campbell M. et al. (1978)

A comparison of haloperidol and behavior therapy and their interaction in autistic children.

Journal of the American Academy of Child and Adolescent Psychiatry

17(4), pp. 640-655

Read Abstract (New Window)

Campbell M. , Cueva J. E. (1995)

Psychopharmacology in child and adolescent psychiatry: a review of the past seven years: Part 1

Journal of the American Academy of Child and Adolescent Psychiatry

34(9), pp. 1124-1132

Read Abstract (New Window)

Campbell M. et al. (1982)

The effects of haloperidol on learning and behavior in autistic children.

Journal of Autism and Developmental Disorders

12(2), pp. 167-175

Read Abstract (New Window)

Canitano R. (2005)

Clinical experience with topiramate to counteract neuroleptic induced weight gain in 10 individuals with autistic spectrum disorders.

Brain and Development

27(3), pp, 228-232

Read Abstract (New Window)

Canitano R. , Scandurra V. (2011)

Psychopharmacology in autism: An update.

Progress in Neuro-Psychopharmacology and Biological Psychiatry

35(1), pp. 18-28.

Read Abstract (New Window)

Canitano R. , Scandurra V. (2008)

Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents.

Neuropsychiatric Disease and Treatment

4(4), pp. 723-730

Read Abstract (New Window) Read Full (New Window)

Canitano R. (2006)

Self injurious behavior in autism: clinical aspects and treatment with risperidone.

Journal of Neural Transmission

113(3), pp. 425-431

Read Abstract (New Window)

Capone G. et al. (2008)

Risperidone use in children with Down syndrome, severe intellectual disability, and comorbid autistic spectrum disorders: A naturalistic study.

Journal of Developmental and Behavioral Pediatrics

29(2), pp. 106-116

Read Abstract (New Window)

Carroll D. et al. (2014)

Examination of aggression and self injury in children with autism spectrum disorders and serious behavioral problems.

Child and Adolescent Psychiatric Clinics of North America

January, 23(1), pp. 57-72.

Read Abstract (New Window)

Chavez B. et al. (2007)

Atypical antipsychotics in children with pervasive developmental disorders.

Pediatric Drugs

9(4), pp. 249-266

Read Abstract (New Window)

Chavez B. , Chavez-Brown M. , Rey J. (2006)

Role of risperidone in children with autism spectrum disorder.

Annals of Pharmacotherapy

40(5), pp. 909-916

Read Abstract (New Window)

Ching H. , Pringsheim T. (2012)

Aripiprazole for autism spectrum disorders (ASD).

Cochrane Database of Systematic Reviews

Read Abstract (New Window) Read Full (New Window)

Cohen D. et al. (2013)

Risperidone or aripiprazole in children and adolescents with autism and/or intellectual disability: A Bayesian meta-analysis of efficacy and secondary effects.

Research in Autism Spectrum Disorders

7(1), pp. 167-175.

Read Abstract (New Window)

Cop E. , Oner P. , Oner O. (2011)

Risperidone and double incontinence in a child with autism.

Journal of Child and Adolescent Psychopharmacology

21(6), pp. 647-648

Read Full (New Window)

Copur. M. , Erdoǧan A. (2011)

Risperidone rechallenge for marked liver function test abnormalities in an autistic child.

Recent Patents on Endocrine, Metabolic and Immune Drug Discovery

5(3), pp. 237-239.

Read Abstract (New Window)

Corson A. et al. (2004)

A retrospective analysis of quetiapine in the treatment of pervasive developmental disorders.

Journal of Clinical Psychiatry

65(1), pp. 1531-1536

Read Abstract (New Window)

Coury D. (2011)

Review: little evidence of clear benefit for most medical treatments for children with autism spectrum disorders.

Evidence Based Mental Health

May, 127(5),

Read Abstract (New Window) Read Full (New Window)

Coury D. et al. (2012)

Use of psychotropic medication in children and adolescents with autism spectrum disorders.

Pediatrics

130 S69-76.

Read Abstract (New Window) Read Extract (New Window)

Curran M. (2011)

Aripiprazole: in the treatment of irritability associated with autistic disorder in pediatric patients.

Pediatric Drugs

13(3), pp. 197-204

Read Abstract (New Window)

Cysneiros R. M. et al. (2009)

May the best friend be an enemy if not recognized early: possible role of omega-3 against cardiovascular abnormalities due to antipsychotics in the treatment of autism.

Arquivos de Neuro-Psiquiatria

67(3), pp. 922-926.

Read Abstract (New Window) Read Full (New Window)